HIV News and Research

RSS

COVID-19 vaccination induces highly variable immunity among the immunocompromised

Researchers in the United States have conducted a study showing that the humoral (antibody) immunity induced by vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – varies significantly among immunocompromised individuals.

4 Jul 2021

Structure-guided T cell vaccine design could offer broad protection SARS-CoV-2 variants

Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind.

2 Jul 2021

The use of flavonoids as antiviral agents against SARS-CoV-2

Researchers in Iran have undertaken a comprehensive review of flavonoids and their antiviral potential against SARS-CoV-2.

2 Jul 2021

California lawmakers push feds to allow a therapy that pays meth users to abstain

In his multiple attempts to overcome a methamphetamine addiction that ground through two decades of his life, Tyrone Clifford Jr. remembers well the closest he came. "The most success I had," he said, "is when my dealer was in jail."

2 Jul 2021

Study explores lectins from plants, fungi, algae and cyanobacteria as pan-coronavirus inhibitors

In a recently published article scientists have provided a detailed description of the utility of mannose-specific lectins in preventing coronavirus infections. They have specifically explained how mannose-specific lectins derived from plants, algae, fungi, and bacteria selectively bind N-glycans present on the surface of viral spike protein and how such interactions can be medically utilized to control coronavirus transmission.

1 Jul 2021

UC screening program helps detect HIV outbreaks among persons who inject drugs

Newly published research shows that a screening program in the University of Cincinnati Medical Center Emergency Department helped detect an outbreak of HIV among persons who inject drugs in Hamilton County, Ohio, from 2014-18.

30 Jun 2021

Is the SARS-CoV-2 delta variant threatening vaccine efficacy?

A new study in the UK, by researchers at Imperial College London, The Francis Crick Institute and the University of Glasgow, explores the loss of coronavirus disease 2019 (COVID-19) vaccine efficacy against the virus behind the current pandemic caused by the emergence of newer variants that have undergone mutational escape.

30 Jun 2021

New biomarkers can predict HIV remission after antiretroviral therapy interruption

New biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are critical for the development of new therapeutic strategies that can achieve infection control without ART, a condition defined as functional cure.

29 Jun 2021

Analysis: Why we’ll likely never know whether a covid lab leak happened in China

Early in this century, post-SARS, and in a period when China started allowing more students and scientists to study abroad, collaboration and exchange between American and Chinese scientists blossomed.

29 Jun 2021

SARS-CoV-2 test in 20 minutes with FISH

A collaboration from the University of Oxford and the University of Warwick has led to research into a novel method of viral detection through rapid fluorescence in situ hybridization (FISH) in order to effectively detect the SARS-CoV-2 virus within 20 minutes.

29 Jun 2021

Differences in monocyte subsets between severe COVID-19 and long COVID

Researchers in the United States and Costa Rica have identified differences in the proportions of monocyte subsets that occur in severe cases of coronavirus disease 2019 (COVID-19) following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and post-acute sequelae of COVID-19 (PASC), often referred to as “Long COVID”.

28 Jun 2021

Researcher receives $2.5 million award to curb HIV infection among people who inject drugs

International organizations and countries around the world are working to eliminate HIV/AIDS by 2030. To reach this goal, new approaches are needed--particularly among difficult-to-reach groups such as people who inject drugs (PWID), who are 30 times more likely to contract HIV/AIDS compared with the general population.

28 Jun 2021

People living with HIV/AIDS more likely to have suicidal thoughts and die from suicide

A new study by researchers at Penn State College of Medicine indicates that people living with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) - approximately 38 million worldwide - are more likely to have suicidal thoughts and die from suicide than members of the general population.

28 Jun 2021

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

A new review article published in the journal Antibiotics reports the presence of a large number of bioactive compounds in microalgae that target chemical structures present only in their structure.

28 Jun 2021

The WHO didn’t reverse its position on kids and Covid vaccines

A social media post circulating on Facebook and Instagram claims that the World Health Organization recently flipped its policy recommendation about children receiving a Covid-19 vaccine.

25 Jun 2021

Special type of stem cell can reduce the amount of HIV virus

In a groundbreaking study, a team of UC Davis researchers has discovered a special type of stem cell that can reduce the amount of the virus causing AIDS, boosting the body's antiviral immunity and repairing and restoring the gut's lymphoid follicles damaged by the simian immunodeficiency virus (SIV), the equivalent of the human immunodeficiency virus (HIV) in non-human primates.

24 Jun 2021

Research suggests people living with HIV/AIDS may be less susceptible to SARS-CoV-2

Researchers in India have conducted a study showing that the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – was lower among people living with HIV and AIDS than among the general population.

23 Jun 2021

Indian SARS-CoV-2 variant has unique infection and immune escape strategy say researchers

Researchers have conducted a study suggesting that the B.1.617 lineage of SARS-CoV-2 that emerged in India has evolved a unique strategy.

23 Jun 2021

Natural compound myricetin shows antiviral potential against SARS-CoV-2

New findings from a team of Chinese researchers suggest natural compounds — specifically the flavonoid myricetin — could also be a potential drug candidate for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

23 Jun 2021

Vaccinated individuals previously infected with SARS-CoV-2 show robust neutralization of the B.1.1.7 variant

New research published in the journal Viruses suggests recovering from a coronavirus disease 2019 (COVID-19) infection provides immunity against the B.1.1.7 (or UK) variant. The time when the previous infection took place and the variant involved in prior infection influenced cross-neutralization.

23 Jun 2021

HIV News and Research

COVID-19 vaccination induces highly variable immunity among the immunocompromised

Structure-guided T cell vaccine design could offer broad protection SARS-CoV-2 variants

The use of flavonoids as antiviral agents against SARS-CoV-2

California lawmakers push feds to allow a therapy that pays meth users to abstain

Study explores lectins from plants, fungi, algae and cyanobacteria as pan-coronavirus inhibitors

UC screening program helps detect HIV outbreaks among persons who inject drugs

Is the SARS-CoV-2 delta variant threatening vaccine efficacy?

New biomarkers can predict HIV remission after antiretroviral therapy interruption

Analysis: Why we’ll likely never know whether a covid lab leak happened in China

SARS-CoV-2 test in 20 minutes with FISH

Differences in monocyte subsets between severe COVID-19 and long COVID

Researcher receives $2.5 million award to curb HIV infection among people who inject drugs

People living with HIV/AIDS more likely to have suicidal thoughts and die from suicide

Could microalgae-derived antiviral compounds combat SARS-CoV-2 and other viruses?

The WHO didn’t reverse its position on kids and Covid vaccines

Special type of stem cell can reduce the amount of HIV virus

Research suggests people living with HIV/AIDS may be less susceptible to SARS-CoV-2

Indian SARS-CoV-2 variant has unique infection and immune escape strategy say researchers

Natural compound myricetin shows antiviral potential against SARS-CoV-2

Vaccinated individuals previously infected with SARS-CoV-2 show robust neutralization of the B.1.1.7 variant

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News